Abstract
Researchers have discovered a significant link between a reduction in death from COVID-19 with prior use of the diabetes drug metformin. In a study published in Frontiers in Endocrinology in January 2021, Shalev and colleagues found a threefold decrease in death from COVID-19 among patients with type 2 diabetes who were taking metformin before their COVID-19 diagnosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
